Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / France

Co-funded partnership · Running

ERDERA European Rare Diseases Research Alliance

Coordinator
Institut National De La Sante Et De La Recherche Medicale, France
Runs
1 September 2024 to 31 August 2031
Status
Running
EU funding
€56.3m
Total cost
€145.8m
Partners
178 organisations in 38 countries
Type
Co-funded partnership
Grant agreement
101156595

What the project is doing

In the project's own words, from its summary on CORDIS.

The European Rare Diseases Research Alliance (ERDERA) aims to improve the health and well-being of the 30 million people living with a rare disease in Europe, by making Europe a world leader in Rare Disease (RD) research and innovation, to support concrete health benefits to rare disease patients, through better prevention, diagnosis and treatment. This Partnership will deliver a RD ecosystem that builds on the successes of previous programmes by supporting robust patient need-led research, developing new diagnostic methods and pathways, spearheading the digital transformational change connecting the dots between care, patient data and research, while ensuring strong alignment of strategies in RD research across countries and regions.

Structuring goal-oriented public-private collaborations targeted at interventions all along the R&D value chain will ensure that the journey from knowledge to patient impact is expedited, thereby optimising EU innovation potential in RD. To support its ambition and missions ERDERA has been designed as a comprehensive and integrated ecosystem of which structure can be compared to an institute encompassing three main parts: (i) funding, (ii) internal (in house) Clinical Research Network that implements research activities targeting clinical trial readiness of RDs and accelerating diagnosis and translation of research discovery into improved patient care, and (iii) related supporting services (Data, Expertise, Education and Training) as well as an acceleration hub that serve external and internal RD community, all supported by all-embracing coordination and strategy and foundational (inter)national alignment.

Topics

Who is involved

OrganisationCityCountryRole
Institut National De La Sante Et De La Recherche MedicaleParisFranceCoordinator
Ait Austrian Institute of Technology GmbHWienAustriaParticipant
Biobanks and Biomolecular Resources Research Infrastructure Consortium (bbmri-Eric)GrazAustriaParticipant
Fonds Zur Förderung Der Wissenschaftlichen ForschungWienAustriaParticipant
Paris-Lodron-Universitat SalzburgSalzburgAustriaParticipant
Sigmund Freud Privatuniversitat Wien GmbHWienAustriaParticipant
St. Anna Kinderkrebsforschung GmbHWienAustriaParticipant
Department of Health Government of Western AustraliaEast PerthAustraliaAssociatedpartner
Fonds De La Recherche Scientifique- FnrsBruxelles / BrusselBelgiumParticipant
Fonds Voor Wetenschappelijk Onderzoek-VlaanderenBruxelles / BrusselBelgiumParticipant
Institut De Pathologie Et De Genetique ASBLGosseliesBelgiumParticipant
Katholieke Universiteit LeuvenLeuvenBelgiumParticipant
SciensanoElseneBelgiumParticipant
Service Public De WallonieNamurBelgiumParticipant
Ucb BiopharmaBruxelles / BrusselBelgiumAssociatedpartner
Universiteit AntwerpenAntwerpenBelgiumParticipant
Universiteit GentGentBelgiumParticipant
Universiteit HasseltHasseltBelgiumParticipant
Vib VzwZwijnaarde - GentBelgiumParticipant
Bulgarian National Science FundSofiaBulgariaParticipant
Medical University SofiaSofiaBulgariaParticipant
Redki Bolesti BulgariaSofiaBulgariaParticipant
Canadian Institutes of Health ResearchOttawa OntarioCanadaAssociatedpartner
Children's Hospital of Eastern Ontario Research Institute IncOttawaCanadaAssociatedpartner
Fonds De Recherche Du Quebec - SanteMontreal QuebecCanadaAssociatedpartner
MicyrnVancouver, British ColumbiaCanadaAssociatedpartner
F. Hoffmann-La Roche AGBaselSwitzerlandAssociatedpartner
Schweizerischer Nationalfonds Zur Forderung Der Wissenschaftlichen ForschungBernSwitzerlandAssociatedpartner
Idryma Erevnas Kai KainotomiasNicosiaCyprusParticipant
Thalassaemia International FederationLefkosiaCyprusParticipant
Agentura Pro Zdravotnicky Vyzkum Ceske Republiky Azv CrPrahaCzechiaThird party
Fakultni Nemocnice Motol a HomolkaPraha 5CzechiaParticipant
Ministerstvo Zdravotnictvi Ceske RepublikyPrahaCzechiaParticipant
Bundesinstitut Fur Impfstoffe Und Biomedizinische ArzneimittelLangenGermanyParticipant
Bundesministerium Fuer Forschung Technologie Und RaumfahrtBonnGermanyParticipant
Centogene GmbHRostockGermanyParticipant
Charite - Universitaetsmedizin BerlinBerlinGermanyParticipant
Checkimmune GmbHBerlinGermanyParticipant
Deutsche Forschungsgemeinschaft eVBonnGermanyAssociatedpartner
Deutsches Zentrum Fur Luft - Und Raumfahrt eVKolnGermanyParticipant
Eberhard Karls Universitaet TuebingenTuebingenGermanyParticipant
Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung eVMunchenGermanyParticipant
Johann Wolfgang Goethe-Universitaet Frankfurt Am MainFrankfurt Am MainGermanyParticipant
Klinikum Der Ludwig-Maximilians-Universitat MunchenMunchenGermanyThird party
Ludwig-Maximilians-Universitaet MuenchenPlaneggGermanyParticipant
Miltenyi Biotec BV & Co KgBergisch GladbachGermanyAssociatedpartner
Technische Universitaet MuenchenMuenchenGermanyParticipant
Universitaetsklinikum AachenAachenGermanyParticipant
Universitaetsklinikum FreiburgFreiburgGermanyParticipant
Universitatsklinikum HeidelbergHeidelbergGermanyParticipant
Aarhus UniversitetshospitalAarhusDenmarkParticipant
Copenhagen Economics ASKobenhavn KDenmarkParticipant
InnovationsfondenKobenhavn KDenmarkParticipant
Region HovedstadenHillerodDenmarkParticipant
Region Nordjylland (north Denmark Region)AalborgDenmarkParticipant
Region SyddanmarkVejleDenmarkParticipant
Sihtasutus Eesti TeadusagentuurTartuEstoniaParticipant
SotsiaalministeeriumTallinnEstoniaParticipant
Tartu UlikoolTartuEstoniaParticipant
Enosi Spanion Asthenon ElladosAthinaGreeceParticipant

And 118 more organisations. Full list on CORDIS.

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI